Ads
related to: worldwide clinical trials- Meet the Team
Discuss Your Clinical Trial
With Our Top Experts.
- About Us
Get In Touch
Let Us Know How We Can Help.
- Request Info or Proposal
Fast & Easy. Submit Your Request
And We'll Be In Touch.
- CRO Quality Ratings
Explore Worldwide Awards,
Accolades & Reviews over 32 years.
- Tour Our New BioA Lab
Large And Small Molecule Processing
Along With Powerful Analysis Tools
- Cell & Gene Therapy
On Time, On Budget Gene Therapy
Clinical Development. Contact Us.
- Meet the Team
cancer.osu.edu has been visited by 10K+ users in the past month
Search results
Panoramic Health Elevates Kidney Care Innovation With Appointment of Dr. Navdeep Tangri as Senior...
The Joplin Globe· 3 hours agoTEMPE, AZ / ACCESSWIRE / May 29, 2024 / Building on its commitment to pioneering advancements in kidney care, Panoramic Health, the nation's largest integrated nephrology practice network, proudly ...
Terran Biosciences prepares for trials of schizophrenia drug
Clinical Trials Arena via Yahoo Finance· 5 days agoSchizophrenia landscape Schizophrenia is a chronic and debilitating mental illness that affects...
Introducing Peanut Products in Infancy Prevents Peanut Allergy Into Adolescence, NIH Reports
Sierra Sun Times· 3 hours agoNIH study finds protection lasts no matter how often kids eat peanuts in later childhood. May 29, 2024 – Feeding children peanut products regularly from infancy to age 5 years reduced the rate ...
Pennsylvania boy is headed to California for a clinical trial that might help save his life | Helen...
Philly.com· 5 days agoThis isn’t the column I was hoping to write after introducing readers to Jax Ramirez in 2022, a...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing ...
WFRV 5 Green Bay· 4 days agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session ...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
FOX 5 San Diego· 4 days agoIn the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) ...
Earnings call: Nanobiotix reports Q1 2024 results, advances with NBTXR3
Investing.com· 6 days agoSignificant strides were made in their collaboration with Janssen on the NBTXR3 development plan,...
Earnings call: IceCure reports 30% increase in Q1 product sales By Investing.com
Investing.com· 5 hours agoIceCure Medical (ICCM), a company specializing in cryoablation treatments, has reported a 30%...
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional...
Digital Journal· 1 day agoNapo's goal is to redefine what is possible in supportive care, providing hope and improving outcomes for patients worldwide. Napo's crofelemer drug product candidate is the ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 hours agoJeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical ...
Ads
related to: worldwide clinical trialscancer.osu.edu has been visited by 10K+ users in the past month